Surgical Treatments for Shoulder Instability
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two surgical treatments for individuals with shoulder instability, specifically those who have experienced shoulder dislocation two or more times. It compares the Bankart repair, a common technique for shoulder repair, with an experimental method called anatomic glenoid reconstruction (also known as the Anatomic Glenoid Reconstruction Procedure). The goal is to determine which approach better prevents future dislocations and improves shoulder function. Ideal participants have experienced multiple shoulder dislocations and show specific bone loss on imaging scans like X-rays or MRIs. As an unphased trial, this study allows participants to contribute to valuable research that could enhance treatment options for shoulder instability.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown promising safety results for the Bankart repair and Anatomic Glenoid Reconstruction (AAGR) in treating shoulder instability. Research indicates that the AAGR is very safe, with no reports of shoulder dislocation after surgery, suggesting it effectively maintains shoulder stability.
Similarly, the Bankart repair has demonstrated good outcomes. Studies found that most patients regain shoulder stability and can return to sports. Serious issues, such as infections, are very rare, occurring in less than 1% of cases.
Both treatments are generally well-tolerated with low rates of serious problems. However, discussing personal risks and benefits with a doctor is important.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for shoulder instability because they offer innovative surgical approaches that could improve patient outcomes. Anatomic Glenoid Reconstruction is distinctive due to its all-arthroscopic technique, which involves an additional medal portal for bone graft insertion, potentially enhancing graft placement precision and stability. Meanwhile, Bankart Repair uses suture-anchor fixation and arthroscopic tying techniques to address labral detachments, with flexibility for surgeons to tailor the procedure to individual patient needs. These techniques aim to provide more effective stabilization of the shoulder joint, potentially leading to better recovery and reduced recurrence of instability, compared to traditional open surgeries.
What evidence suggests that this trial's treatments could be effective for shoulder instability?
This trial will compare two surgical treatments for shoulder instability: Anatomic Glenoid Reconstruction (AGR) and Bankart Repair. Research has shown that arthroscopic anatomic glenoid reconstruction (AAGR), one treatment in this trial, safely and effectively treats recurring shoulder instability. Studies have found that AAGR delivers excellent short- and mid-term results, with recurrence rates similar to the well-known Latarjet procedure. Its safety profile is also similar to that of the Bankart repair.
Conversely, arthroscopic Bankart repair (ABR), another treatment option in this trial, effectively manages shoulder instability, particularly after a first-time dislocation. It results in fewer complications and a high rate of return to usual activities. However, some studies have found a higher chance of recurrence compared to the Latarjet procedure. Both techniques offer viable options for treating shoulder instability, each with distinct advantages.678910Who Is on the Research Team?
Ivan Wong, MD
Principal Investigator
Nova Scotia Health Authority
Are You a Good Fit for This Trial?
This trial is for individuals with recurrent shoulder dislocations who have specific bone loss visible on imaging. It's not suitable for those with uncontrolled diabetes, pregnancy, severe illness, massive rotator cuff tears, certain levels of bone loss, posterior instability, shoulder paralysis, cancer, generalized laxity or previous surgery on the affected shoulder.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either arthroscopic Bankart repair or arthroscopic anatomic glenoid reconstruction (AAGR) for anterior shoulder instability
Follow-up
Participants are monitored for safety, recurrence of dislocation, and functional outcomes
Long-term Follow-up
Participants continue to be monitored for long-term outcomes and recurrence rates
What Are the Treatments Tested in This Trial?
Interventions
- Anatomic Glenoid Reconstruction
- Bankart Repair
Anatomic Glenoid Reconstruction is already approved in European Union, United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator